Cite
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS G12D -mutated non-small-cell lung cancer.
MLA
Ricciuti, B., et al. “Dissecting the Clinicopathologic, Genomic, and Immunophenotypic Correlates of KRAS G12D -Mutated Non-Small-Cell Lung Cancer.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 33, no. 10, Oct. 2022, pp. 1029–40. EBSCOhost, https://doi.org/10.1016/j.annonc.2022.07.005.
APA
Ricciuti, B., Alessi, J. V., Elkrief, A., Wang, X., Cortellini, A., Li, Y. Y., Vaz, V. R., Gupta, H., Pecci, F., Barrichello, A., Lamberti, G., Nguyen, T., Lindsay, J., Sharma, B., Felt, K., Rodig, S. J., Nishino, M., Sholl, L. M., Barbie, D. A., … Luo, J. (2022). Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS G12D -mutated non-small-cell lung cancer. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 33(10), 1029–1040. https://doi.org/10.1016/j.annonc.2022.07.005
Chicago
Ricciuti, B, J V Alessi, A Elkrief, X Wang, A Cortellini, Y Y Li, V R Vaz, et al. 2022. “Dissecting the Clinicopathologic, Genomic, and Immunophenotypic Correlates of KRAS G12D -Mutated Non-Small-Cell Lung Cancer.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 33 (10): 1029–40. doi:10.1016/j.annonc.2022.07.005.